1
|
Chen T, Qin X, Jiang J, He B. Diagnostic indicators and lifestyle interventions of metabolic-associated fatty liver disease. Front Nutr 2024; 11:1424246. [PMID: 38946789 PMCID: PMC11211376 DOI: 10.3389/fnut.2024.1424246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2024] [Accepted: 06/05/2024] [Indexed: 07/02/2024] Open
Abstract
MAFLD has become a major global health problem and is the leading cause of liver disease worldwide. The disease progresses from a simple fatty liver to gradual fibrosis, which progresses to cirrhosis and even hepatocellular liver cancer. However, the methods currently used for diagnosis are invasive and do not facilitate clinical assessment of the condition. As a result, research on markers for the diagnosis of MAFLD is increasing. In addition, there are no clinical medications for the treatment of MAFLD, and lifestyle interventions remain effective in the prevention and treatment of MAFLD. In this review, we attempt to make a summary of the emerging diagnostic indicators and effective lifestyle interventions for MAFLD and to provide new insights into the diagnosis and treatment of MAFLD.
Collapse
Affiliation(s)
- Tianzhu Chen
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
| | - Xiang Qin
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
| | - Jianping Jiang
- Hangzhou Lin’an Traditional Chinese Medicine Hospital, Affiliated Hospital, Hangzhou City University, Hangzhou, China
| | - Beihui He
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
- School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China
| |
Collapse
|
2
|
Cordeiro KC, Scaffo J, Flexa BN, Gama CCA, Ferreira MA, Cruz RAS, Aguiar-Alves F, Rocha L, Machado FP, Fernandes CP. Characterization of bergamot essential oil: chemical, microbiological and colloidal aspects. BRAZ J BIOL 2024; 83:e275622. [PMID: 38422264 DOI: 10.1590/1519-6984.275622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Accepted: 12/12/2023] [Indexed: 03/02/2024] Open
Abstract
Citrus bergamia is a citric species known as bergamot. The species is widely used due to its derivatives, such as juices, extracts, and essential oil. Specifically, the bergamot essential oil (BEO) is of great interest, with a chemical composition rich in terpenes and esters. Considering its chemical composition, bioactivity, and great economic potential, the characterization of BEO should be studied. However, this essential oil is almost unexplored in terms of a characterization associated with colloids. Chemical characterization was carried out by gas-chromatography coupled to a mass spectrometer and by gas-chromatography coupled to a flame ionization detector. Antibacterial activity against Staphylococcus aureus and Escherichia coli was carried out to confirm the bioactivity of this important essential oil. Dynamic light scattering analysis was performed to create a pattern of droplet size distribution of BEO. Major compounds of BEO were linalyl acetate, limonene, and linalool. The BEO was active against E. coli and presented a MIC value of 2.000 µg/mL, while values of MIC and MBC higher than 2.000 µg/mL were observed for S. aureus. The dynamic light scattering analysis revealed a mean hydrodynamic diameter of 65.7 ± 2.2 nm. After a 1:10 dilution it was observed reduction of mean diameter and enhancement of the percentagem of low size droplets, resepctively 44.1 ± 1.2 nm and 14.5 ± 0.5 nm (28.8 ± 1.2%). Higher droplets and reduced polydispersity index were observed after 1:100 dilution. In the present study, the chemical characterization was in accordance with the species, as the characteristic chemical markers of the species were found. Moreover, it has presented antibacterial activity as expected for the BEO. The analysis of the colloid showed a pattern of droplet size distribution following the Ostwald ripening mechanism after dilution.
Collapse
Affiliation(s)
- K C Cordeiro
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - J Scaffo
- Universidade Federal Fluminense - UFF, Laboratório de Epidemiologia Molecular e Biotecnologia, Niterói, RJ, Brasil
- Universidade Federal Fluminense - UFF, Programa de Pós-graduação em Ciências Aplicadas à Produtos para Saúde, Niterói, RJ, Brasil
| | - B N Flexa
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - C C A Gama
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - M A Ferreira
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - R A S Cruz
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
| | - F Aguiar-Alves
- Universidade Federal Fluminense - UFF, Laboratório de Epidemiologia Molecular e Biotecnologia, Niterói, RJ, Brasil
- Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy, Department of Pharmaceutical Sciences, Florida, FL, United States
| | - L Rocha
- Universidade Federal Fluminense - UFF, Laboratório de Tecnologia de Produtos Naturais, Niterói, RJ, Brasil
| | - F P Machado
- Universidade Federal Fluminense - UFF, Laboratório de Tecnologia de Produtos Naturais, Niterói, RJ, Brasil
| | - C P Fernandes
- Universidade Federal do Amapá - UNIFAP, Programa de Pós-graduação em Ciências Farmacêuticas, Macapá, AP, Brasil
- Universidade Federal do Amapá - UNIFAP, Laboratório de Nanobiotecnologia Fitofarmacêutica, Macapá, AP, Brasil
- Universidade Federal Fluminense - UFF, Laboratório de Epidemiologia Molecular e Biotecnologia, Niterói, RJ, Brasil
| |
Collapse
|